Motorcycle Campaign Spreads Ebola Prevention Messages in Eastern DR Congo
Dozens of motorcycle taxi drivers in eastern Democratic Republic of Congo participated in an awareness campaign carrying Ebola prevention messages and countering misinformation about the outbreak. The campaign, organized with WHO support, took place in Bunia and Rwampara in Ituri province, the region most affected by the current outbreak. The effort reflects ongoing challenges in combating disease skepticism and building public trust during health emergencies.
Motorcycle taxi drivers in eastern DR Congo took to the streets on Wednesday wearing "Stop Ebola" T-shirts and carrying prevention banners as part of a WHO-supported awareness campaign. The initiative targeted Bunia and Rwampara in Ituri province, the epicenter of the current Ebola outbreak, and aimed to counter persistent misinformation and skepticism about the disease within affected communities. Health officials have identified public doubt and resistance as significant obstacles to controlling the outbreak. The campaign represents a grassroots approach to public health communication, leveraging local transportation networks and trusted community figures to disseminate accurate information. This effort comes as the DRC faces its seventeenth recorded Ebola outbreak since the virus's first emergence in 1976.
What's missing
The specific number of confirmed Ebola cases in the current outbreak, the case fatality rate, and the timeline of the outbreak's progression are not provided in either source.
How coverage differed
Euronews provides straightforward reporting on the immediate campaign details and WHO involvement. The Independent frames the outbreak within a broader historical and political narrative, emphasizing colonial legacy and Western geopolitical involvement as structural causes of disease vulnerability, rather than focusing on the current prevention efforts.
What different sources said
- The IndependentLeft
The pain of DRC’s past echoes into this new Ebola outbreak
- EuronewsCenter
Congo motorcyclists mobilise as Ebola outbreak fuels fear
Related
Study Shows Experimental Drug Could Preserve Muscle Mass in GLP-1 Weight-Loss Users
A clinical trial published in Nature Medicine found that combining the weight-loss drug tirzepatide with an experimental antibody called apitegromab helped patients retain approximately 55% more muscle mass compared to tirzepatide alone. GLP-1 medications, now used by roughly one in eight US adults, typically result in 25-40% of weight loss coming from lean body mass rather than fat. The findings could address a side effect known as "Ozempic butt" and have implications for treating age-related muscle loss and other conditions.
FDA Grants Emergency Approval for Over-the-Counter Screwworm Treatment for Pets
The FDA has granted emergency use authorization for nitenpyram, an over-the-counter tablet, to treat New World screwworm infections in dogs and cats. This marks the first generic animal drug approved for screwworm treatment as cases have emerged in Texas, New Mexico, and other states after a decade without US cases. The approval provides pet owners with a rapid treatment option as screwworm, a parasitic infection spread by flies, resurfaces in the country.
Protein Coffee Gains Popularity as Consumers Seek Convenient Nutrition
Protein coffee, which combines protein powder with morning coffee, is growing in popularity among fitness enthusiasts, busy professionals, and older adults seeking convenient ways to increase protein intake. The trend reflects broader interest in protein consumption timing and muscle maintenance, particularly among adults over 40. Nutrition experts say it can be useful for those who skip breakfast, but should not replace a balanced meal.